The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 18, 2023

Filed:

Jun. 01, 2018
Applicant:

The Regents of the University of Michigan, Ann Arbor, MI (US);

Inventors:

Yu Lei, Ann Arbor, MI (US);

Yee Sun Tan, Ann Arbor, MI (US);

Kanokwan Sansanaphongpricha, Ann Arbor, MI (US);

Duxin Sun, Ann Arbor, MI (US);

Hongwei Chen, Ann Arbor, MI (US);

Hongxiang Hu, Ann Arbor, MI (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 47/69 (2017.01); A61K 47/64 (2017.01); A61P 35/00 (2006.01); A61K 39/00 (2006.01); A61K 39/02 (2006.01); A61K 39/118 (2006.01); A61K 39/385 (2006.01); B82Y 5/00 (2011.01);
U.S. Cl.
CPC ...
A61K 47/6929 (2017.08); A61K 39/0003 (2013.01); A61K 39/0011 (2013.01); A61K 39/02 (2013.01); A61K 39/118 (2013.01); A61K 39/385 (2013.01); A61K 47/643 (2017.08); A61K 47/646 (2017.08); A61K 47/6923 (2017.08); A61P 35/00 (2018.01); A61K 2039/55561 (2013.01); A61K 2039/572 (2013.01); A61K 2039/60 (2013.01); A61K 2039/622 (2013.01); B82Y 5/00 (2013.01);
Abstract

The present invention provides methods, compositions, systems, and kits comprising nano-satellite complexes and/or serum albumin carrier complexes, which are used for modulating antigen-specific immune response (e.g., enhancing anti-tumor immunity). In certain embodiments, the nano-satellite complexes comprise: a) a core nanoparticle complex comprising a biocompatible coating surrounding a nanoparticle core; b) at least one satellite particle attached to, or absorbed to, the biocompatible coating; and c) an antigenic component conjugated to, or absorbed to, the at least one satellite particle component. In certain embodiments, the complexes further comprise: d) an type I interferon agonist agent. In some embodiments, the serum albumin complexes comprise: a) at least part of a serum albumin protein, b) an antigenic component conjugated to the carrier protein, and c) a type I interferon agonist agent.


Find Patent Forward Citations

Loading…